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and hemodynamic measurements. The rabbits in the Sham group
(n¼14) received the same procedure without abdominal aorta
constriction. Eight weeks after the index procedure, ex vivo electro-
physiological parameters were determined. The protein expression
levels of RYR2, phosphorylated RYR2 (RYR2p), FKBP12 was deter-
mined using western-blot. The level of RYR2 phosphorylation was
deﬁned as the ratio of RYR2p to RYR2.
RESULTS Compared to the Sham group, the LVH group had a signif-
icantly shorter left ventricular effective refractory period (122.75 
10.31 ms vs 95.71  16.31 ms, P <0.001). Six isolated hearts (6/8) in the
LVH group occurred inducible ventricular tachycardia or ventricular
ﬁbrillation under program stimulation, while none (0/8) in the Sham
group occurred arrhythmia (P ¼0.007). All hearts (6/6) in the HF group
occurred spontaneous ventricular ﬁbrillation, while the other two
groups didn’t have. Compared to the Sham group, the LVH group had
signiﬁcantly higher protein expression of RYR2, RYR2p, and FKBP12
(P <0.05), while the level of RYR2 phosphorylation didn’t differ
signiﬁcantly between these two groups. Compared to the sham group,
the HF group had signiﬁcantly lower protein levels of RYR2 and
FKBP12, but higher levels of RYR2p and RYR2 phosphorylation ratio
(P <0.05).
CONCLUSIONS The present study showed that despite of the altered
expression levels of RYR2 in both LVH and HF, the ratio of RYR2
phosphorylation only increased in HF rather than in LVH, suggesting
RYR2 hyperphosphorylation may play an important role in the
development of hypertensive HF. Furthermore, the altered RYR2
expression and phosphorylation level might be translated into more
vulnerable electrophysiological characteristics.
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OBJECTIVES Osteoglycin (OGN) plays important roles in cardiovas-
cular disease. However, the relationship between OGN and angio-
genesis remains unknown. Therefore, we sought to investigate the
effect of OGN on ischemia-induced angiogenesis and address the
underlying mechanisms.
METHODS Expression of OGN on endothelial cells (ECs) in angio-
genic tissue was detected. Limb ischemia model was established in
OGN knockout (KO) (n¼12) and wild type (WT) (n¼12) mice. Laser
Doppler imaging was used to estimate perfusion recovery. Mean-
while, aortic rings assay was used as ex vivo model of angiogenesis.
Small interfering RNA was used to knock down OGN expression in
culturing human umbilical vein endothelial cells (HUVECs), and cell
functions were assessed in subsequent study. Protein-protein inter-
action was revealed by co-immunoprecipitation assay. And molecu-
lar docking was performed to predict the binding site of OGN to
VEGFR2.
RESULTS OGN was down regulated in intermuscular endothelial cells
during angiogenesis in patients of peripheral artery disease and mice
model of limb ischemia. OGN knockout promoted perfusion as
femoral artery ligation. The blood ﬂow recovery of WT mice after
ischemia induction was 24.8%, 44.6% and 63.5% respectively at day4,
day7 and day14, while that of KO mice was 46.5%, 71.5%, and 83.0%
coordinately. Capillary density indicating by CD31 positive staining
was also higher in OGN KO mice in the gastrocnemicus muscle of the
ischemia limb. But no difference of inﬂammatory cells inﬁltration
between two groups was observed. Aortic rings isolated from OGN KO
mice had stronger sprouting than those from WT ones. In vitro study
revealed tube formation, proliferation, and migration of HUVECs were
enhanced in OGN knockdown group, compared with negative control
group. OGN knockdown did not alter protein level of VEGF or
VEGFR2, but changed activation of VEGFR2 and its downstream
signaling pathways as Akt an ERK1/2. Co-immunoprecipitation assay
revealed association of OGN and VEGFR2 both in vitro and in vivo.
And OGN was found to modulate interaction of VEGF and VEGFR2.
Molecular docking showed OGN docked into the binding pocket of
VEGFR2 on the extracellular domain2 and domain3, which is the exact
binding site of VEGF.
CONCLUSIONS This study demonstrates the crucial role of OGN
in the setting of ischemia-induced angiogenesis. Down regulation
of OGN promoted endothelial cell functions and angiogenic path-
ways. In mechanism, this phenomenon can be attributed to OGNbinding to VEGFR2 and modulation of VEGF-VEGFR2 signaling
pathway.
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OBJECTIVES This research will explore the expression of Hippo
signal transduction pathway in the patients with hypertrophic car-
diomyopathy and the regulation of this pathway and its related gene
in the development of cardiac hypertrophy, and explore the possible
role of Hippo signal transduction pathway in hypertrophic
cardiomyopathy.
METHODS Myocardial tissues of 32 patients with hypertrophic car-
diomyopathy, who accept the Marrow’s surgery in Beijing Anzhen
Hospital from September 2011 to April 2013 and 4 cases of normal
myocardial tissue were harvested and then protein and RNA of these
tissues were also extracted and tested to detect the expression of
Hippo signal transduction pathways in the protein and the mRNA
level clinical specimens. Speciﬁc cardiomyocytes YAP transgenic
mice, as well as the Isoproterenol (ISO) cardiac hypertrophic model,
are used to explore the possible molecular mechanism of Hippo signal
transduction pathway in the process of promoting cardiac hypertro-
phy. Using mouse primary cultured cardiomyocytes explore the
mechanism of this pathway in vitro.
RESULTS The expression of protein and mRNA of MST in tissues of
hypertrophic cardiomyopathy is less than normal myocardial tissue,
the expression of protein and mRNA of YAP in tissues of hypertrophic
cardiomyopathy is more than normal myocardial tissue and the
expression of YAP-S127 declines. Same results are obtained in HCM
model mice.
CONCLUSIONS The abnormal expression of Hippo signal trans-
duction pathways regulates myocardial cell hyperplasia and prolifer-
ation and promotes the occurrence of hypertrophic cardiomyopathy.
Low expression of MST in Hippo pathway can upregulate the activity
of the pathway downstream gene (YAP) and the other speciﬁc genes to
regulate the proliferation of myocardial cells, which affects the
myocardial hypertrophy and participates in the development of hy-
pertrophic cardiomyopathy.
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OBJECTIVES 3,3’-Diindolylmethane (DIM) is a natural component of
cruciferous plants. Previous studies have shown that DIM has multi-
ple physiological effects including anti - angiogenic, anti-inﬂamma-
tory and anti-cancer effect. However, little is known about the role of
DIM on myoﬁbroblast differentiation and extracellular matrix (ECM)
production. This study aimed to investigated the effect of DIM on
myoﬁbroblast differentiation and ECM production in neonatal rat
cardiac ﬁbroblasts induced by transforming growth factor b1 (TGF-b1).
METHODS The neonatal rat cardiac ﬁbroblasts in vitro were stimu-
lated with TGF-b1 (1 mmol/L) for 48 h to induce myoﬁbroblast differ-
entiation. Cell viability was examined by CCK8, the percentage of
positive cardiac ﬁbroblasts was measured with immunoﬂuorescence
staining. The mRNA expression levels of ﬁbrotic markers were
measured with Real-time PCR and the protein expression levels of
AKT and glycogen synthase kinase-3b (GSK-3b) were examined with
Western Blotting analysis.
RESULTS Our data showed that DIM could dramatically blunt the
percentage of positive cardiac ﬁbroblasts which express a-smooth
muscle actin (a-SMA) protein induced by TGF-b1, and reduced the
mRNA and protein expressions of a-SMA. Moreover, DIM also signif-
icantly decreased the mRNA expression of ﬁbrotic markers (Collagen I,
